Clinical Trial Update: A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials

View source ↗

Summary

A clinical trial update about outcomes in relapsed/refractory multiple myeloma patients treated with T-cell redirectors outside of clinical trials; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Relapsed/Refractory Multiple Myeloma (RRMM) | Status: RECRUITING